feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
BioInvent: Good Safety Profile for BT-001
Research Note
2022-06-27
10:03
Redeye makes an adjustment to the project’s LOA based on results from BT-001’s phase I trial, part A.
RR
Richard Ramanius
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans